Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
slept most of the day; chill; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (slept most of the day) and CHILLS (chill) in an 82-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. Concomitant products included Influenza vaccine from 28-Sep-2025 to 28-Sep-2025 for an unknown indication. On 06-Oct-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On 07-Oct-2025, the patient experienced HYPERSOMNIA (slept most of the day) and CHILLS (chill). On 08-Oct-2025, HYPERSOMNIA (slept most of the day) and CHILLS (chill) had resolved. The patient received the flu vaccine 8 days before the covid 19 vaccination and indicated no significant medical history. On 06-Oct-2025, the patient received the Moderna COVID-19 vaccination. On 07-Oct-2025, she experienced violent chills for the entire day and slept most of the day. This was the first time it had happened. The symptoms were gone the next day, on 08-Oct-2025. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.
Influenza vaccine